Literature DB >> 25280785

Cystic fibrosis (cf) and ovarian reserve: A cross-sectional study examining serum anti-mullerian hormone (amh) in young women.

C A Schram1, A L Stephenson2, T G Hannam3, E Tullis2.   

Abstract

BACKGROUND: Reduced female fertility in CF is believed to be due to thick cervical mucous, poor nutritional status, functional hypogonadotropic hypogonadism and possibly increased inflammation. Literature suggests that reduced ovarian reserve may also play a role.
METHODS: 20 women with CF and 20 controls age 18-35 years were recruited. Serum anti-mullerian hormone (AMH), estradiol and follicle stimulating hormone (FSH) were assessed as well as antral follicle count (AFC) using transvaginal ultrasound.
RESULTS: Women with CF had significantly lower AMH levels than controls (17.8+/-4.7 vs. 33.2+/-21.0 pmol/L respectively; p=0.004). There were no differences in estradiol, FSH or AFC.
CONCLUSIONS: Women with CF have reduced ovarian reserve which may contribute to sub-fertility. CF care providers should consider referring women with CF to fertility specialists early to optimize chances of pregnancy.
Copyright © 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-mullerian hormone; Cystic fibrosis; Fertility; Pregnancy

Mesh:

Substances:

Year:  2014        PMID: 25280785     DOI: 10.1016/j.jcf.2014.09.008

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  5 in total

1.  Ovarian reserve in women with sickle cell disease.

Authors:  Julia Kopeika; Adeola Oyewo; Sinthiya Punnialingam; Nivedita Reddy; Yacoub Khalaf; Jo Howard; Sofia Mononen; Eugene Oteng-Ntim
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

2.  Reduced Ovarian Function in Female Rheumatoid Arthritis Patients Trying to Conceive.

Authors:  Jenny Brouwer; Radboud J E M Dolhain; Johanna M W Hazes; Jenny A Visser; Joop S E Laven
Journal:  ACR Open Rheumatol       Date:  2019-07-04

3.  The Prognosis of ART Is Not Altered in Cystic Fibrosis Women: A Case-Report Study.

Authors:  Inès Braham; Adeline Morisot; Samir Boukaïdi; Marie Perceval; Isabelle Durieu; Christine Rousset-Jablonski; Sylvie Hieronimus; Sylvie Leroy; Nicolas Chevalier
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-21       Impact factor: 5.555

Review 4.  Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era.

Authors:  Raksha Jain; Jennifer L Taylor-Cousar
Journal:  J Pers Med       Date:  2021-05-15

5.  Treatment of cystic fibrosis related bone disease.

Authors:  Jagdeesh Ullal; Katherine Kutney; Kristen M Williams; David R Weber
Journal:  J Clin Transl Endocrinol       Date:  2021-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.